ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,474Medicare Part D Prescriptions Filled, Including Refills

Rank: 27 out of 546

$644K Total Retail Price of All Prescriptions

Rank: 28 out of 546

495 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maine
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 495 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

9% of this provider’s 495 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 9,322 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $65 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maine
METOPROLOL TARTRATE 376 352 1 6
LEVOTHYROXINE SODIUM 361 335 2 3
LISINOPRIL 357 300 3 1
WARFARIN SODIUM 295 293 4 13
SIMVASTATIN 295 266 4 2
OMEPRAZOLE 278 227 6 4
FUROSEMIDE 271 266 7 5
METOPROLOL SUCCINATE 227 187 8 17
HYDROCODONE-ACETAMINOPHEN 227 171 S3 8 8
AMLODIPINE BESYLATE 221 218 10 9
ATORVASTATIN CALCIUM 203 181 11 11
PANTOPRAZOLE SODIUM 192 180 12 18
SERTRALINE HCL 171 134 13 14
POLYETHYLENE GLYCOL 3350 169 156 14 68
LOSARTAN POTASSIUM 152 140 15 24
ATENOLOL 141 131 16 12
CITALOPRAM HBR 141 129 16 21
METFORMIN HCL 141 100 16 10
HYDROCHLOROTHIAZIDE 117 110 19 7
RANITIDINE HCL 108 87 20 23
LANTUS 104 94 21 46
PREDNISONE 103 103 22 29
POTASSIUM CHLORIDE 98 94 23 30
CYMBALTA 98 65 23 37
ISOSORBIDE MONONITRATE ER 97 93 25 32
DIGOXIN 93 93 26 62
ADVAIR DISKUS 92 89 27 20
TAMSULOSIN HCL 91 80 28 35
TRAMADOL HCL 91 91 28 19
ZOLPIDEM TARTRATE 89 71 30 26
GABAPENTIN 83 80 31 16
DONEPEZIL HCL 82 82 32 31
PRAVASTATIN SODIUM 77 69 33 33
ALLOPURINOL 76 76 34 41
RISPERIDONE 71 71 35 47
COMBIVENT 70 66 36 71
FENTANYL 70 58 S2 36 50
LYRICA 66 32 38 69
SPIRIVA 65 65 39 28
CRESTOR 65 36 39 36
CLOPIDOGREL 64 64 41 77
KLOR-CON M20 64 62 41 57
QUETIAPINE FUMARATE 63 61 43 72
TRAZODONE HCL 62 45 44 25
GLIMEPIRIDE 59 47 45 114
SPIRONOLACTONE 59 59 45 82
VERAPAMIL ER 58 49 47 110
CARBIDOPA-LEVODOPA 57 52 48 76
OXYCODONE HCL 57 42 S2 48 15
LEVETIRACETAM 55 55 50 95
TRIAMCINOLONE ACETONIDE 54 38 51 112
PAROXETINE HCL 54 48 51 43
LOVASTATIN 52 51 53 22
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 30, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.